BIO Protocol (BIO) is a decentralized platform designed to revolutionize biotechnology by enabling global communities—including scientists, patients, and investors—to collectively fund, develop, and co-own new drugs and scientific intellectual property (IP). By leveraging blockchain technology, BIO Protocol aims to accelerate biotech innovation through decentralized funding, governance, and liquidity mechanisms. $PHA
The platform introduces BioDAOs, which are decentralized autonomous organizations focused on specific scientific missions or areas. These BioDAOs facilitate community-driven funding and development of biotech projects, promoting a more inclusive and efficient approach to scientific research and commercialization. $WIF #
BIO serves as the native governance token of the BIO Protocol ecosystem. Token holders can participate in decision-making processes, signal support for various BioDAOs, and vote on future incentives within the network. This token-based governance model ensures that the community has a direct influence on the direction and priorities of the platform.
As of December 29, 2024, BIO Protocol's price is approximately $0.951, with an all-time high of $0.997 reached on December 27, 2024.
For a unique research article, consider exploring "BIO Protocol is pushing scientific funding onchain," which discusses how BIO Protocol offers initial funding seeds for approved BioDAOs and connects them with service providers within their network.
By integrating decentralized science (DeSci) principles, BIO Protocol aims to democratize biotech innovation, making it more accessible and efficient for all stakeholders involved.
